These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2578234)

  • 1. Occurrence of posttransplant donor-specific cell-mediated lympholysis nonreactivity in renal allograft recipients with perioperative transfusions only.
    Goulmy E; Blokland E; Fassbinder W; Persijn G; van Rood JJ
    Transplantation; 1985 Jan; 39(1):105-7. PubMed ID: 2578234
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell-mediated lympholysis studies in renal allograft recipients.
    Goulmy E; Persijn G; Blokland E; D'Amaro J; van Rood JJ
    Transplantation; 1981 Mar; 31(3):210-7. PubMed ID: 7015616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor specific cell-mediated lympholysis (CML) by peripheral blood lymphocytes (PBL) from recipients with long-term renal grafts.
    Imai T; Takasaki E; Beck Y; Inoue S; Tseng CC; Sugimoto H; Nagao T; Akiyama N; Uchida H
    Transplant Proc; 1992 Aug; 24(4):1424-6. PubMed ID: 1386698
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective loss of functional antidonor cytolytic T cell precursors following donor-specific blood transfusions in long-term renal allograft recipients.
    Hadley GA; Anderson CB; Mohanakumar T
    Transplantation; 1992 Aug; 54(2):333-7. PubMed ID: 1386694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation tolerance in heart transplant recipients as demonstrated by unresponsiveness in cell-mediated lympholysis.
    Wijngaard PL; Schuurman HJ; Meyling FH; Jambroes G; Borleffs JC
    Hum Immunol; 1992 Jul; 34(3):167-72. PubMed ID: 1429041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA regulates postrenal transplant CML nonreactivity.
    Goulmy E; Blokland E; Persijn G; Paul LC; Wilmink J; van Rood JJ
    J Immunol; 1985 Nov; 135(5):3082-6. PubMed ID: 3900203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of donor-specific cellular suppressor activity in donor-specific cell-mediated lympholysis unresponsiveness in renal transplant patients.
    Wramner L; Olausson M; Söderström T; Lindholm L; Rydberg L; Brynger H
    Transplantation; 1987 Sep; 44(3):390-5. PubMed ID: 2957836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of HLA-haploidentical blood transfusions on donor-specific immune responsiveness.
    Leivestad T; Thorsby E
    Transplantation; 1984 Feb; 37(2):175-81. PubMed ID: 6198792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated lympholysis in Kaposi's sarcoma after renal allograft. Report of two cases.
    Rodríguez SG; Martín RS; Araujo HA; Alvarez CL; Samaniego MC
    Transplantation; 1986 Dec; 42(6):697-9. PubMed ID: 3538555
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.
    Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM
    Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed leucocyte culture, pre- transplant transfusions and renal allograft rejection.
    Shons AR; Etheredge EE; Callender CO; Schmidtke JR; Simmons RL; Najarian JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):464-70. PubMed ID: 4278196
    [No Abstract]   [Full Text] [Related]  

  • 12. The time course of cell-mediated lympholysis in rat hepatic allograft recipients pretreated with a single donor-specific blood transfusion.
    Katsumori T; Yamaguchi Y; Mori K; Makino Y; Misumi M; Takata N; Goto M; Kikuchi N; Ogawa M
    Transplantation; 1992 Sep; 54(3):531-6. PubMed ID: 1412734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct cell mediated lympholysis. A test of allograft-rejection in human kidney recipients.
    Grunnet N; Kristensen T; Kornerup HJ; Kissmeyer-Nielsen F
    Tissue Antigens; 1975 May; 5(4):280-5. PubMed ID: 50635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of donor-specific blood transfusion enhancement of rat renal allografts on cytotoxic activity and phenotypes of peripheral blood lymphocytes, splenocytes, and graft-infiltrating cells.
    Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
    Transplantation; 1991 Feb; 51(2):451-9. PubMed ID: 1994542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of specific nonreactivity in human cadaveric renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Tissue Antigens; 1976 May; 7(5):281-90. PubMed ID: 132717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic selection of renal transplant donors and recipients: blood transfusions].
    Seignalet J; Mourad G; Mion C
    Nephrologie; 1984; 5(3):123-9. PubMed ID: 6387521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of allograft function to the development of donor specific cellular nonreactivity in human cadaveric allograft recipients.
    Rashid A; Sengar DP; Couture RA; Harris JE
    Trans Am Soc Artif Intern Organs; 1976; 22():229-33. PubMed ID: 133496
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of pretransplant donor-specific transfusions in renal transplantation.
    Leivestad T; Flatmark A; Hirschberg H; Thorsby E
    Transplant Proc; 1982 Jun; 14(2):370-3. PubMed ID: 6214064
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal transplantation: cyclosporin A and antibody development after donor-specific transfusion.
    al-Muzairai IA; Innes A; Hillis A; Stewart KN; Bone JM; Catto GR; Macleod AM
    Kidney Int; 1989 Apr; 35(4):1057-63. PubMed ID: 2651767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.